UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC - INTELLIA THERAPEUTICS INC ownership

INTELLIA THERAPEUTICS INC's ticker is NTLA and the CUSIP is 45826J105. A total of 160 filers reported holding INTELLIA THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 1.73 and the average weighting 0.4%.

Quarter-by-quarter ownership
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ownership history of INTELLIA THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$11,465,475
+9.8%
512,309
+34.9%
0.00%
-25.0%
Q1 2024$10,443,841
-20.7%
379,638
-12.1%
0.00%
-20.0%
Q4 2023$13,172,046
+2.3%
432,012
+6.0%
0.01%
-16.7%
Q3 2023$12,881,514
-17.5%
407,385
-2.7%
0.01%
-25.0%
Q2 2023$15,605,8800.0%418,7250.0%0.01%0.0%
Q1 2023$15,605,880
+13.7%
418,725
+6.5%
0.01%
+14.3%
Q4 2022$13,720,283
-99.9%
393,244
-2.4%
0.01%
-46.2%
Q3 2022$22,556,076,000
+17.3%
403,075
+8.5%
0.01%
+30.0%
Q2 2022$19,223,922,000
-17.2%
371,405
+16.3%
0.01%0.0%
Q1 2022$23,211,089,000
-32.0%
319,404
+10.7%
0.01%
-23.1%
Q4 2021$34,122,765,000
-12.1%
288,589
-0.3%
0.01%
-18.8%
Q3 2021$38,811,741,000
-12.4%
289,316
+5.8%
0.02%
-15.8%
Q2 2021$44,281,091,000
+138.7%
273,492
+18.3%
0.02%
+137.5%
Q1 2021$18,554,235,000
+21.4%
231,191
-17.7%
0.01%
+14.3%
Q4 2020$15,286,344,000
+1081.6%
280,999
+331.8%
0.01%
+600.0%
Q3 2020$1,293,729,000
+2.7%
65,077
+8.6%
0.00%0.0%
Q2 2020$1,259,961,000
+111.1%
59,941
+22.8%
0.00%
Q1 2020$596,739,000
-1.1%
48,793
+18.6%
0.00%
Q4 2019$603,567,000
+5.4%
41,143
-4.1%
0.00%
Q3 2019$572,608,000
+91.6%
42,892
+135.0%
0.00%
Q2 2019$298,834,000
+20.9%
18,255
+111.4%
0.00%
Q3 2018$247,134,0008,6350.00%
Other shareholders
INTELLIA THERAPEUTICS INC shareholders Q3 2018
NameSharesValueWeighting ↓
Darwin Global Management, Ltd. 1,859,926$301,141,00048.58%
Burrage Capital Management LLC 63,634$10,303,00010.33%
Elmwood Wealth Management, Inc. 67,174$10,876,0005.73%
HIMENSION CAPITAL (SINGAPORE) PTE. LTD. 300,327$48,626,0004.72%
Discovery Value Fund 929,669$150,523,0004.08%
Ikarian Capital, LLC 294,400$47,667,0003.85%
Ally Bridge Group (NY) LLC 93,127$15,078,0003.75%
GREAT POINT PARTNERS LLC 100,000$16,191,0003.40%
ARK Investment Management 7,684,441$1,244,188,0002.32%
REGENTS OF THE UNIVERSITY OF CALIFORNIA 111,440$18,043,0002.30%
View complete list of INTELLIA THERAPEUTICS INC shareholders